What is the latest FERMENTA stock price?
The latest stored price for FERMENTA is Rs 427.95 as of 2026-11-03.
gimli
FERMENTA stock AI analysis
FERMENTA Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
FERMENTA BIOTECH LTD. is a small-cap stock in Healthcare. This Gimli page shows the latest available FERMENTA price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹427.95
1W return
-4.40%
1M return
-22.65%
3M return
-16.37%
6M return
+37.58%
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
32.76
Turnover
₹1.94 cr
Why it can matter in screens
- Momentum: FERMENTA is below 50DMA, below 200DMA; RSI is 32.76.
- Returns: 1D +1.78%, 1W -4.40%, 1M -22.65%, 3M -16.37%, 1Y n/a.
- Trend levels: 52W high ₹582.65, 52W low ₹293.80, off high -26.55%.
- Liquidity: latest turnover is ₹1.94 cr; volume vs 20D is +0.40%.
- Valuation/profitability: PE n/a, PB n/a, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR +12.01%, 3Y profit CAGR n/a.
Quick Answers
Is FERMENTA above its 50DMA and 200DMA?
FERMENTA is below 50DMA, below 200DMA. The latest 50DMA is 486.83 and the latest 200DMA is n/a.
What are FERMENTA PE, ROE and ROCE?
FERMENTA has PE n/a, ROE n/a, and ROCE n/a in Gimli's latest available snapshot.
How has FERMENTA performed recently?
FERMENTA has returned -22.65% over 1 month, -16.37% over 3 months, and n/a over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 121.82 cr | 22.43 cr | 9.74 cr | 3.40 |
| 2026-03-31 | 126.64 cr | 25.07 cr | 18.60 cr | 6.66 |
| 2025-12-31 | 140.48 cr | 28.08 cr | 12.02 cr | 4.36 |
| 2025-09-30 | 135.65 cr | 32.07 cr | 18.03 cr | 6.48 |
| 2025-06-30 | 145.03 cr | 37.00 cr | 21.60 cr | 7.49 |
| 2025-03-31 | 139.85 cr | 40.84 cr | 34.39 cr | nan |
| 2024-12-31 | n/a | n/a | n/a | n/a |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 474.15 cr | 121.66 cr | 64.28 cr | 21.96 |
| 2025-03-31 | 442.21 cr | 111.79 cr | 67.62 cr | 23.18 |
| 2024-03-31 | 315.24 cr | 36.14 cr | -18.74 cr | -6.49 |
| 2023-03-31 | 337.38 cr | -12.69 cr | -57.00 cr | -19.75 |
| 2022-03-31 | 395.49 cr | 83.46 cr | 30.24 cr | 10.48 |
Balance sheet
No recent data available.
Cash flow
No recent data available.
Shareholding Trend
No recent data available.
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 424,658.30 cr | 35.053345 | +15.50% | +3.72% |
| DIVISLAB | DIVI S LABORATORIES LTD | 267,167.60 cr | 91.684145 | +18.37% | +47.91% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 157,377.11 cr | 74.094685 | +16.87% | +28.16% |
| LAURUSLABS | LAURUS LABS LIMITED | 125,408.69 cr | 114.827348 | +21.77% | +138.16% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 124,833.39 cr | 27.818646 | +16.04% | +26.46% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 121,354.29 cr | 57.614911 | +22.62% | +7.87% |
| DRREDDY | DR. REDDY S LABORATORIES | 113,923.95 cr | 40.698752 | +7.80% | +14.41% |
| CIPLA | CIPLA LTD | 112,841.65 cr | 38.950805 | +8.80% | -7.58% |
Try these prompts
- Analyze FERMENTA BIOTECH. with valuation, momentum and industry peers
- Compare FERMENTA with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare FERMENTA with other Healthcare stocks
Data snapshot: 2026-11-03. Not investment advice.